Synopsis
Synopsis
0
KDMF
0
VMF
0
FDF
0
Australia
DRUG PRODUCT COMPOSITIONS
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
Annual Reports
NA
Finished Drug Prices
NA
1. Amethocaine
2. Ametop
3. Dicaine
4. Hydrochloride, Tetrracaine
5. Pantocaine
6. Pontocaine
7. Tetracaine
8. Tetracaine Monohydrochloride
9. Tetrakain
10. Tetrracaine Hydrochloride
1. 136-47-0
2. Tetracaine Hcl
3. Butethanol
4. Amethocaine Hydrochloride
5. Pantocaine
6. Curtacain
7. Menonasal
8. Anethaine
9. Dicainum
10. Tetracaine, Hcl
11. Tetracaine (hydrochloride)
12. Butylocaine
13. 2-(dimethylamino)ethyl 4-(butylamino)benzoate Hydrochloride
14. Tetocaine
15. Tetraca
16. Tetracainehydrochloride
17. 5nf5d4opci
18. 2-(dimethylamino)ethyl P-(butylamino)benzoate Monohydrochloride
19. Nsc-757337
20. 4-(butylamino)benzoic Acid 2-(dimethylamino)ethyl Ester Hydrochloride
21. Benzoic Acid, 4-(butylamino)-, 2-(dimethylamino)ethyl Ester, Monohydrochloride
22. Mls000069780
23. Tetracaine Hydrochloride (pontocaine)
24. Anethain
25. Decicain
26. Decicaine
27. Dessicain
28. Intercaine
29. Leocaine
30. Pantocain
31. Smr000058522
32. Tonexol
33. Anacel
34. Gingicain M
35. Dsstox_cid_22448
36. Dsstox_rid_80027
37. Dsstox_gsid_42448
38. Tetracainium Chloridum
39. Tetracaine Chlorhydrate
40. 2-(dimethylamino)ethyl 4-(butylamino)benzoate;hydrochloride
41. Viractin
42. Tetracaine Monohydrochloride
43. Amethocaine Monohydrochloride
44. Sr-01000075240
45. Ncgc00016049-02
46. Cas-136-47-0
47. Einecs 205-248-5
48. Unii-5nf5d4opci
49. Exactacain
50. Amethocalne Hcl
51. Tetracaine Hydrochloride [usp:jan]
52. Mfcd00038912
53. P-butylaminobenzoyl-2-dimethylaminoethanol Hydrochloride
54. 2-dimethylaminoethanol 4-n-butylaminobenzoate Hydrochloride
55. Pontocaine Hydrochloride
56. 2-(dimethylamino)ethyl P-(butylamino)benzoate Hydrochloride
57. Tetracaini Hydrochloridum
58. Opera_id_1220
59. P-(butylamino)benzoic Acid, 2-(dimethylamino)ethyl Ester, Hydrochloride
60. Dicainum [who-ip]
61. Schembl24370
62. Mls002222164
63. Protocaine Hydrochloride (tn)
64. Spectrum1500564
65. 4-butylaminobenzoic Acid Dimethylaminoethyl Ester Hcl
66. Chebi:9469
67. Chembl1255654
68. Dtxsid6042448
69. Tetracaine For System Suitability
70. Tetracaine Hydrochloride, >=99%
71. Hms1569d04
72. Hms1921c17
73. Pharmakon1600-01500564
74. Act04762
75. Bcp26339
76. Hy-b0473
77. Tox21_110290
78. Tox21_501211
79. Ac-774
80. Ccg-39266
81. Nsc757337
82. S2573
83. Tetracaine Hydrochloride [mi]
84. Tetracaine Hydrochloride (jp17/usp)
85. Tetracaine Hydrochloride [jan]
86. Akos015888160
87. Tox21_110290_1
88. Ks-5059
89. Lp01211
90. Nsc 757337
91. Benzoic Acid, P-(butylamino)-, 2-(dimethylamino)ethyl Ester, Monohydrochloride
92. Tetracaine Hydrochloride [mart.]
93. Tetracaine Hydrochloride [vandf]
94. Ncgc00016049-07
95. Ncgc00094458-01
96. Ncgc00094458-02
97. Ncgc00094458-03
98. Ncgc00094458-04
99. Ncgc00094458-05
100. Ncgc00261896-01
101. Tetracaine Hydrochloride [usp-rs]
102. Tetracaine Hydrochloride [who-dd]
103. Tetracaine Hydrochloride [who-ip]
104. 53762-93-9
105. Amethocaine Hydrochloride [who-ip]
106. Db-042341
107. Eu-0101211
108. Ft-0603346
109. Ft-0674941
110. Sw196411-3
111. T1688
112. Tetracaine Hydrochloride [green Book]
113. Tetracaine Hydrochloride [orange Book]
114. D00741
115. T 7508
116. Tetracaine Hydrochloride [ep Monograph]
117. Tetracaine Hydrochloride [usp Monograph]
118. Tetracaini Hydrochloridum [who-ip Latin]
119. 136t470
120. A807078
121. Kovanaze Component Tetracaine Hydrochloride
122. Tetracaine Hydrochloride, Sigma Reference Standard
123. Q-201806
124. Sr-01000075240-1
125. Sr-01000075240-6
126. Q27262597
127. Tetracaine Hydrochloride Component Of Kovanaze
128. Tetracaine Hydrochloride, Meets Usp Testing Specifications
129. Tetracaine Hydrochloride 1.0 Mg/ml In Acetonitrile (as Free Base)
130. Tetracaine Hydrochloride, European Pharmacopoeia (ep) Reference Standard
131. Benzoic Acid, 4-(butylamino)-, 2-(dimethylamino)ethyl Ester,monohydrochloride
132. Tetracaine For System Suitability, European Pharmacopoeia (ep) Reference Standard
133. Tetracaine Hydrochloride, Pharmaceutical Secondary Standard; Certified Reference Material
134. Tetracaine Hydrochloride, United States Pharmacopeia (usp) Reference Standard
Molecular Weight | 300.82 g/mol |
---|---|
Molecular Formula | C15H25ClN2O2 |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 4 |
Rotatable Bond Count | 9 |
Exact Mass | 300.1604557 g/mol |
Monoisotopic Mass | 300.1604557 g/mol |
Topological Polar Surface Area | 41.6 Ų |
Heavy Atom Count | 20 |
Formal Charge | 0 |
Complexity | 249 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
Anesthetics, Local
Drugs that block nerve conduction when applied locally to nerve tissue in appropriate concentrations. They act on any part of the nervous system and on every type of nerve fiber. In contact with a nerve trunk, these anesthetics can cause both sensory and motor paralysis in the innervated area. Their action is completely reversible. (From Gilman AG, et. al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th ed) Nearly all local anesthetics act by reducing the tendency of voltage-dependent sodium channels to activate. (See all compounds classified as Anesthetics, Local.)
Shuangda Pharmaceutical has a world-class first-class production line, having GMP, FDA and other regulatory certifications.
Date of Issue : 2023-11-06
Valid Till : 2026-11-05
Written Confirmation Number : SD230069
Address of the Firm :
Nuray is an expert in the synthesis of Niche novel APIs, the first to launch Generics, NCEs, Advanced Intermediates // USFDA certified.
LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
GDUFA
DMF Review : Reviewed
Rev. Date : 2022-11-09
Pay. Date : 2022-09-27
DMF Number : 34462
Submission : 2021-06-22
Status : Active
Type : II
Certificate Number : R1-CEP 2010-256 - Rev 01
Issue Date : 2018-09-11
Type : Chemical
Substance Number : 57
Status : Valid
Date of Issue : 2021-03-12
Valid Till : 2024-01-24
Written Confirmation Number : WC-0291n
Address of the Firm :
NDC Package Code : 52038-004
Start Marketing Date : 2020-01-14
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (25kg/25kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 22487
Submission : 2008-12-31
Status : Active
Type : II
NDC Package Code : 66219-0002
Start Marketing Date : 2009-12-04
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (25kg/25kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 4065
Submission : 1981-02-20
Status : Active
Type : II
Certificate Number : CEP 2017-205 - Rev 01
Issue Date : 2024-01-29
Type : Chemical
Substance Number : 57
Status : Valid
Registration Number : 220MF10198
Registrant's Address : Route du Simplon 1,36,CH-1902 Evionnaz,Switzerland
Initial Date of Registration : 2008-09-09
Latest Date of Registration : --
NDC Package Code : 17381-100
Start Marketing Date : 2010-05-18
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : Reviewed
Rev. Date : 2018-06-01
Pay. Date : 2018-04-16
DMF Number : 32062
Submission : 2017-10-24
Status : Active
Type : II
NDC Package Code : 17381-100
Start Marketing Date : 2010-05-18
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : Reviewed
Rev. Date : 2015-03-26
Pay. Date : 2015-03-18
DMF Number : 8221
Submission : 1989-09-21
Status : Active
Type : II
NDC Package Code : 22568-1029
Start Marketing Date : 2021-06-01
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 22609
Submission : 2009-03-12
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 22609
Submission : 2009-03-12
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 22487
Submission : 2008-12-31
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2015-03-26
Pay. Date : 2015-03-18
DMF Number : 8221
Submission : 1989-09-21
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 4065
Submission : 1981-02-20
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2018-06-01
Pay. Date : 2018-04-16
DMF Number : 32062
Submission : 2017-10-24
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2022-11-09
Pay. Date : 2022-09-27
DMF Number : 34462
Submission : 2021-06-22
Status : Active
Type : II
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
Patents & EXCLUSIVITIES
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?